335255-05-5Relevant articles and documents
SELECTIVE HDAC1,2 INHIBITORS
-
Paragraph 0281; 0286; 0287, (2018/06/04)
Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with HDAC1 and/or HDAC2 activity.
Glutamate receptor antagonists
-
, (2008/06/13)
The present invention is a compound of formula wherein X is an ethynediyl group, R1, R2and R3are as defined in the specification.